Literature DB >> 31088835

Radiation-Induced DNA Damage Cooperates with Heterozygosity of TP53 and PTEN to Generate High-Grade Gliomas.

Pavlina K Todorova1, Eliot Fletcher-Sananikone1, Bipasha Mukherjee1, Rahul Kollipara2, Vamsidhara Vemireddy3, Xian-Jin Xie4, Peter M Guida5, Michael D Story1, Kimmo Hatanpaa6, Amyn A Habib3,7, Ralf Kittler2, Robert Bachoo3, Robert Hromas8, John R Floyd9, Sandeep Burma10,9.   

Abstract

Glioblastomas are lethal brain tumors that are treated with conventional radiation (X-rays and gamma rays) or particle radiation (protons and carbon ions). Paradoxically, radiation is also a risk factor for GBM development, raising the possibility that radiotherapy of brain tumors could promote tumor recurrence or trigger secondary gliomas. In this study, we determined whether tumor suppressor losses commonly displayed by patients with GBM confer susceptibility to radiation-induced glioma. Mice with Nestin-Cre-driven deletions of Trp53 and Pten alleles were intracranially irradiated with X-rays or charged particles of increasing atomic number and linear energy transfer (LET). Mice with loss of one allele each of Trp53 and Pten did not develop spontaneous gliomas, but were highly susceptible to radiation-induced gliomagenesis. Tumor development frequency after exposure to high-LET particle radiation was significantly higher compared with X-rays, in accordance with the irreparability of DNA double-strand breaks (DSB) induced by high-LET radiation. All resultant gliomas, regardless of radiation quality, presented histopathologic features of grade IV lesions and harbored populations of cancer stem-like cells with tumor-propagating properties. Furthermore, all tumors displayed concomitant loss of heterozygosity of Trp53 and Pten along with frequent amplification of the Met receptor tyrosine kinase, which conferred a stem cell phenotype to tumor cells. Our results demonstrate that radiation-induced DSBs cooperate with preexisting tumor suppressor losses to generate high-grade gliomas. Moreover, our mouse model can be used for studies on radiation-induced development of GBM and therapeutic strategies. SIGNIFICANCE: This study uncovers mechanisms by which ionizing radiation, especially particle radiation, promote GBM development or recurrence. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31088835      PMCID: PMC6635038          DOI: 10.1158/0008-5472.CAN-19-0680

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  65 in total

1.  A role for common fragile site induction in amplification of human oncogenes.

Authors:  Asaf Hellman; Eitan Zlotorynski; Stephen W Scherer; Joseph Cheung; John B Vincent; David I Smith; Luba Trakhtenbrot; Batsheva Kerem
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

2.  Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma.

Authors:  C T Miller; L Lin; A M Casper; J Lim; D G Thomas; M B Orringer; A C Chang; A F Chambers; T J Giordano; T W Glover; D G Beer
Journal:  Oncogene       Date:  2006-01-19       Impact factor: 9.867

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells.

Authors:  Bipasha Mukherjee; Chase Kessinger; Junya Kobayashi; Benjamin P C Chen; David J Chen; Aloke Chatterjee; Sandeep Burma
Journal:  DNA Repair (Amst)       Date:  2006-03-29

5.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

Authors:  J Jonkers; R Meuwissen; H van der Gulden; H Peterse; M van der Valk; A Berns
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

6.  Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.

Authors:  M Groszer; R Erickson; D D Scripture-Adams; R Lesche; A Trumpp; J A Zack; H I Kornblum; X Liu; H Wu
Journal:  Science       Date:  2001-11-01       Impact factor: 47.728

7.  A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

Authors:  Chris Hunter; Raffaella Smith; Daniel P Cahill; Philip Stephens; Claire Stevens; Jon Teague; Chris Greenman; Sarah Edkins; Graham Bignell; Helen Davies; Sarah O'Meara; Adrian Parker; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; Andy Jenkinson; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; David Richardson; Rebecca Shepherd; Alexandra Small; Helen Solomon; Calli Tofts; Jennifer Varian; Sofie West; Sara Widaa; Andy Yates; Douglas F Easton; Gregory Riggins; Jennifer E Roy; Kymberly K Levine; Wolf Mueller; Tracy T Batchelor; David N Louis; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

8.  Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience.

Authors:  Alberto Broniscer; Weiming Ke; Christine E Fuller; Jianrong Wu; Amar Gajjar; Larry E Kun
Journal:  Cancer       Date:  2004-05-15       Impact factor: 6.860

9.  Unique molecular characteristics of radiation-induced glioblastoma.

Authors:  Andrew M Donson; Nicole S Erwin; B K Kleinschmidt-DeMasters; Jennifer R Madden; Steven O Addo-Yobo; Nicholas K Foreman
Journal:  J Neuropathol Exp Neurol       Date:  2007-08       Impact factor: 3.685

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  9 in total

Review 1.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

2.  Specificity of end resection pathways for double-strand break regions containing ribonucleotides and base lesions.

Authors:  James M Daley; Nozomi Tomimatsu; Grace Hooks; Weibin Wang; Adam S Miller; Xiaoyu Xue; Kevin A Nguyen; Hardeep Kaur; Elizabeth Williamson; Bipasha Mukherjee; Robert Hromas; Sandeep Burma; Patrick Sung
Journal:  Nat Commun       Date:  2020-06-18       Impact factor: 14.919

3.  TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway.

Authors:  Tian Yang; Tianhe Huang; Dongdong Zhang; Miao Wang; Balu Wu; Yufeng Shang; Safat Sattar; Lu Ding; Yin Liu; Hongqiang Jiang; Yuxing Liang; Fuling Zhou; Yongchang Wei
Journal:  Aging (Albany NY)       Date:  2019-10-19       Impact factor: 5.682

4.  Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas.

Authors:  Zijian Zhou; JinHong Wei; Wenbo Jiang
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

Review 5.  Defining the molecular features of radiation-induced glioma: A systematic review and meta-analysis.

Authors:  Jacqueline P Whitehouse; Meegan Howlett; Aniello Federico; Marcel Kool; Raelene Endersby; Nicholas G Gottardo
Journal:  Neurooncol Adv       Date:  2021-08-12

Review 6.  Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable.

Authors:  Amir Barzegar Behrooz; Zahra Talaie; Amir Syahir
Journal:  Pharmaceutics       Date:  2022-08-15       Impact factor: 6.525

7.  Genome-wide CRISPR/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma.

Authors:  Guo-Dong Zhu; Jing Yu; Zheng-Yu Sun; Yan Chen; Hong-Mei Zheng; Mei-Lan Lin; Shi Ou-Yang; Guo-Long Liu; Jie-Wen Zhang; Feng-Min Shao
Journal:  Cell Death Dis       Date:  2021-07-21       Impact factor: 8.469

8.  Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence.

Authors:  Pengfei Wu; Wei Yang; Jianxing Ma; Jingyu Zhang; Maojun Liao; Lunshan Xu; Minhui Xu; Liang Yi
Journal:  Oncol Lett       Date:  2019-10-11       Impact factor: 2.967

9.  Flavonoids from Rosa roxburghii Tratt prevent reactive oxygen species-mediated DNA damage in thymus cells both combined with and without PARP-1 expression after exposure to radiation in vivo.

Authors:  Sai-Juan Xu; Xia Wang; Tao-Yang Wang; Zheng-Zhan Lin; Yong-Jian Hu; Zhong-Lin Huang; Xian-Jun Yang; Ping Xu
Journal:  Aging (Albany NY)       Date:  2020-08-29       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.